The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 431.50
Bid: 429.50
Ask: 432.00
Change: -1.50 (-0.35%)
Spread: 2.50 (0.582%)
Open: 439.50
High: 450.50
Low: 431.50
Prev. Close: 433.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIB EBA European Wide Stress Tests 2018

2 Nov 2018 17:32

RNS Number : 2570G
AIB Group PLC
02 November 2018
 

 

 

 

 

02 November 2018

 

AIB Group plc - European Banking Authority (EBA) European Wide Stress Tests 2018

 

CFO Comment on EBA EU Wide Stress Tests

 

"Our result of 11.8% fully loaded CET1 in the adverse scenario demonstrates our high capital base and resilience. With a fully loaded CET1 of 17.9% in September 2018, continued reduction in NPEs and a growing loan book, the balance sheet continues to strengthen and risk profile improves."

-Mark Bourke, CFO

Results of EBA EU Wide Stress Tests

 

AIB Group plc ("AIB") was subject to the 2018 EU‐wide stress test conducted by the European Banking Authority (EBA), in cooperation with the Central Bank of Ireland (CBI), the European Central Bank (ECB), the European Commission (EC) and the European Systemic Risk Board (ESRB).

 

AIB's capital ratios and EBA stress test results are outlined below:

AIB CET 1 Capital Ratios

Sept 2018

Jan 2018

Post-IFRS9

Dec 2017

Dec 2015

CET 1 - Transitional

21.6%

20.8%

20.8%

15.9%

CET 1 - Fully loaded

17.9%

17.0%

17.5%

13.0%

EBA Stress Test Results

 

Stress Test 2018

 

Stress Test 2016

CET 1 - Transitional adverse scenario

 

14.8%

 

7.4%

CET 1 - Fully loaded adverse scenario

 

11.8%

 

4.3%

 

AIB's very strong capital starting level (based on January CET1 17.0%) and our proven ability to generate capital give us significant comfort about the overall result (CET1 11.8% in adverse scenario). The elevated levels of NPEs and the static nature of the test contribute to higher than average capital depletion under the adverse scenario. No capital action is required for AIB as a result of the EBA Stress Test Results.

 

The EBA stress test is based on the January 2018 static balance sheet and does not reflect current or future improved financial performance, which for 2018 so far includes:

· €3bn reduction in NPEs (including loan portfolio sales of €1.1bn) to €7.2bn September 2018

· Profit before tax €0.8bn for the six months to end June 2018.

 

AIB notes the following:

· AIB is very well capitalised with a CET1 fully loaded ratio at September 2018 of 17.9%, well ahead of our medium term target of 13% and significantly above our SREP requirement (9.725%)[1]

· AIB demonstrated its ability to generate and return capital having increased its dividend by 30% to €326m (FY 2017) from €250m (FY 2016)

· AIB NPEs have reduced materially from €18bn in December 2015 to €10.2bn in Dec 2017, and subsequently to €7.2bn in Sept 2018. This represents a 77% reduction from peak NPEs.

 

 

The results published today by the EBA are point in time projections based on prescribed stress tests methodology and should not be treated as indicative of the future financial performance of AIB.

 

To view the results including disclosure templates published by EBA for AIB please see Appendix 1.

http://www.rns-pdf.londonstockexchange.com/rns/2570G_1-2018-11-2.pdf

 

For further information on AIB's performance year to date, please click see Appendix 2 for our Q3 2018 Trading Update.

http://www.rns-pdf.londonstockexchange.com/rns/2570G_2-2018-11-2.pdf

 

-ENDS-

 

For further information, please contact:

Niamh Hore / Janet McConkey

Orla Bird / Stephen O'Shea

Investor Relations

Media Relations

AIB Bankcentre

AIB Bankcentre

Dublin

Dublin

Tel: +353-1-6411817 / +353-1-6418974

Tel: +353-1-7715375 / +353-1-7720456

email: niamh.a.hore@aib.ie

email: orla.c.bird@aib.ie

janet.e.mcconkey@aib.ie

stephen.p.o'shea@aib.ie

 

 

Important Information and forward-looking statements

This document should be considered with AIB's Annual Financial Report 2017 and Half-Yearly Financial Report 2018, and all other relevant market disclosures, copies of which can be found at the following link: http://aib.ie/investorrelations

This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'aim', 'anticipate', 'target', ' expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking information. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. These are set out in the 'Principal risks and uncertainties' on pages 58 to 68 of the Annual Financial Report 2017 and on page 32 'Update on risk management and governance' of the Half-Yearly Financial Report 2018. In addition to matters relating to the Group's business, future performance will be impacted by Irish, UK and wider European and global economic and financial market considerations. Any forward-looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 58 to 68 of the Annual Financial Report 2017 and on page 32 of the Half-Yearly Financial Report 2018 is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward-looking statement.

 

 

[1] FY 2018 SREP is 9.725%; SREP requirement does not include Pillar 2 Guidance (P2G).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKBDBOBDDNDK
Date   Source Headline
13th May 20247:59 amRNSStabilisation Notice
9th May 20245:11 pmRNSHolding(s) in Company
9th May 20244:53 pmRNSHolding(s) in Company
8th May 202410:33 amRNSTotal Voting Rights
7th May 20245:36 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.